Encepharm

Gottingen, Germany Founded: 2004 • Age: 22 yrs Acquired By Brains On-Line
German Primate Center spinoff, specializing in preclinical in vivo (non-rodent) neurobiology studies

About Encepharm

Encepharm is a company based in Gottingen (Germany) founded in 2004 was acquired by Brains On-Line in May 2016.. Encepharm offers products and services including Microdialysis Services and In Vivo Efficacy Testing. Encepharm operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

  • Headquarter Gottingen, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Encepharm Gmbh
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Brains On-Line

    (May 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Encepharm

Encepharm offers a comprehensive portfolio of products and services, including Microdialysis Services and In Vivo Efficacy Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Measures substances in freely moving animals for neuroscience research

Conducts testing to understand CNS disease mechanisms and treatments

People of Encepharm
Headcount 10000+
Employee Profiles 387
Employee Profiles
People
Marc Giulianotti Mba
Senior Business Development Executive
People
Getachew Sequar
Sr Director Business Development
People
Kerry Colligan
Senior Director, Digital And Growth Marketing
People
Jeff Simons
Director Of Digital Customer Experience

Unlock access to complete

Funding Insights of Encepharm

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Encepharm

Encepharm has secured backing from 1 investor. Prominent investors backing the company include Brains On-Line. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Preclinical development services for CNS disorders and compounds are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Encepharm

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Encepharm

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Encepharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Encepharm

Encepharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Humanized mouse models are developed for preclinical immune drug studies.
domain founded_year HQ Location
Provider of transgenic rodent models and customized cell lines for preclinical development
domain founded_year HQ Location
Preclinical CRO services for CNS and orphan disorders are offered.
domain founded_year HQ Location
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
domain founded_year HQ Location
Animal models are supplied for in-vivo analytical services.
domain founded_year HQ Location
Preclinical contract research organization offering standard GLP and non-GLP services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Encepharm

Frequently Asked Questions about Encepharm

When was Encepharm founded?

Encepharm was founded in 2004.

Where is Encepharm located?

Encepharm is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.

What does Encepharm do?

Encepharm, a spinoff of the German Primate Center (DPZ), offers preclinical RD support services such as pharmacology, ADMEPK, safety testing, behavioral, bioanalytical and histological analysis, target identification and validation and consulting services. They have experience in disease areas such as psychiatric, neurodegenerative and neuroinflammatory, metabolic and respiratory diseases and also in eating disorders. They have access to techniques such as MRI, SPECT, confocal laser microscopy, three-dimensional anatomical mapping through their collaborations with German Primate Center (DPZ), the Medical School University of Göttingen, Max Planck-Institutes, and the Fraunhofer Institute for Toxicology and Experimental Medicine in Hanover.They are AAALAC accredited and can work with both small molecules and biologics.

Who are the top competitors of Encepharm?

Encepharm's top competitors include GenOway, PsychoGenics and Alpha Genesis.

What products or services does Encepharm offer?

Encepharm offers Microdialysis Services and In Vivo Efficacy Testing.

Who are Encepharm's investors?

Encepharm has 1 investor. Key investors include Brains On-Line.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available